NYSE •
Healthcare •
Biotechnology •
Quote as of 05/21/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization1,308.37 mln
Float124 mln
Earnings Date08/03/2026
Piotroski F-Score
2
/ 9
Weak
1-Year Forecast
21.76
Transformational upside
Relative Strength
23
/ 100
Significantly lagging
Debt / Equity
2.21
Very high leverage
ROE
-580
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Biohaven Ltd. is a pharmaceutical company based in New Haven, Connecticut, focused on researching and bringing new medicines to patients with immune system disorders, neurological conditions, and cancer. The company has a broad portfolio of drug candidates at various stages of clinical testing, targeting conditions such as Parkinson's disease, epilepsy, rheumatoid arthritis, obesity, and several types of cancer, among others. A number of additional treatments are in earlier stages of research, addressing diseases ranging from type 1 diabetes to hearing disorders.
